Greenfield-based Elanco Health on Monday announced the $295 million cash sale of future U.S. royalty and milestone rights of ...

Elanco Animal Health Incorporated (NYSE: ELAN) today announced the sale of certain future tiered royalties and commercial ...

Elanco Animal Health Incorporated (NYSE:ELAN) on Monday announced the sale of certain future tiered royalties and commercial ...

In 2023, XDEMVY became the first lotilaner-based product approved for human use and the only FDA-approved medicine for treatment of Demodex ... disease in humans caused by Demodex mites.

In 2023, XDEMVY became the first lotilaner-based product approved for human use and the only FDA-approved medicine for treatment of Demodex ... disease in humans caused by Demodex mites.

a common eyelid disease in humans caused by Demodex mites. The agreement applies to certain tiered royalties associated with Xdemvy's U.S. net sales from April 2025 through August 2033 and ...

Eye mites, or Demodex, are microscopic organisms that live at the base of your eyelashes. Most people have them but in some cases the tiny arachnids can cause Demodex blepharitis, which is a ...